Bi-level Positive Airway Pressure for Respiratory Distress Syndrome in Twins Infants
1 other identifier
interventional
300
1 country
1
Brief Summary
The investigators compared advantages and disadvantages of two forms of noninvasive respiratory support -bi-level positive airway pressure(BiPAP) or nasal continuous positive airway pressure (nCPAP) -as a primary mode of ventilation in preterm twins infants with respiratory distress syndrome
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2017
CompletedFirst Posted
Study publicly available on registry
August 1, 2017
CompletedStudy Start
First participant enrolled
August 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2022
CompletedFebruary 16, 2021
February 1, 2021
5.3 years
July 28, 2017
February 14, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
intubation rate
the baby was intubated
within 7 days
Study Arms (2)
BiPAP
EXPERIMENTALBiPAP as a primary mode of ventilation in one of the preterm infants with respiratory distress syndrome
nCPAP
ACTIVE COMPARATORnCPAP is used as a primary mode of ventilation in another of the preterm infants with respiratory distress syndrome
Interventions
Eligibility Criteria
You may qualify if:
- \. Gestational age (GA) is from 26 to 37 weeks;
- \. Diagnosis of respiratory distress syndrome. The diagnosis of respiratory distress syndrome will be based on clinical manifestations (tachypnea, nasal flaring and or grunting) and chest X-ray findings;
- \. Respiratory distress syndrome Silverman score \>5;
- \. Informed parental consent has been obtained.
You may not qualify if:
- \. Severe respiratory distress syndrome requiring early intubation according to the American Academy of Pediatrics guidelines for neonatal resuscitation;
- \. Major congenital malformations or complex congenital heart disease;
- \. Group B hemolytic streptococcus pneumonia, septicemia, pneumothorax, pulmonary hemorrhage;
- \. Cardiopulmonary arrest needing prolonged resuscitation;
- \. transferred out of the neonatal intensive care unit without treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Pediatrics, Daping Hospital, Third Military Medical University
Chongqing, Chongqing Municipality, 400042, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Shi Yuan, PhD,MD
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 28, 2017
First Posted
August 1, 2017
Study Start
August 15, 2017
Primary Completion
December 15, 2022
Study Completion
December 15, 2022
Last Updated
February 16, 2021
Record last verified: 2021-02